APA (7th ed.) Citation

S, B., S, C., B, L., B, B., T, L., G, R., . . . C, H. (2024). Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3. European journal of haematology, 112(3), 475. https://doi.org/10.1111/ejh.14126

Chicago Style (17th ed.) Citation

S, Bonnet, et al. "Extreme Thrombocytosis with an Aggressive Evolution Harboring a Novel Variant of Calreticulin (CALR) in Exon 3." European Journal of Haematology 112, no. 3 (2024): 475. https://doi.org/10.1111/ejh.14126.

MLA (9th ed.) Citation

S, Bonnet, et al. "Extreme Thrombocytosis with an Aggressive Evolution Harboring a Novel Variant of Calreticulin (CALR) in Exon 3." European Journal of Haematology, vol. 112, no. 3, 2024, p. 475, https://doi.org/10.1111/ejh.14126.